By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon.
Microelectromechanical systems (MEMS) devices, which lab-on-a-chip devices are a subclass of, are sometimes referred to as “micro total analysis systems” (TAS). LOCs may make use of microfluidics, which is the physics, handling, and research of tiny amounts of fluid.
But technically speaking, “lab-on-a-chip” refers to the scaling down of one or more lab processes to chip format, whereas “TAS” is focused on the integration of the entire sequence of lab processes to carry out chemical analysis. When it became apparent that TAS technologies were suitable for uses other than just analysis, the phrase “lab-on-a-chip” was coined.
The Global Smart lab-on-a-chip devices market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
The demand for homecare, preventative care, early diagnosis, accelerating patient recovery, and bettering outcomes, as well as the growing significance of technologies like machine learning, augmented reality, 5G, and digitalization, are all driving growth in the medical device industry.
According to GlobalData’s research on Robotics in Medical Devices: Microfluidic Lab-on-a-Chip, the number of patent applications and grants in the medical devices sector has exceeded 450,000 just in the last few years.
Disruptive technologies in the early stages of application that should be carefully monitored in the emerging innovation stage include camera-guided surgical robots, robotic biopsy endoscopes, and head-mounted displays for surgical navigation.
Robotic exoskeletons, surgical robots, and robotic catheters are just a few of the rapidly developing technologies that have seen rising usage. Robotic lower limb rehabilitation and microfluidic lab-on-a-chip, both of which are currently well-established in the business, are examples of maturing innovation areas.
The businesses at the forefront of each innovation sector are also identified by GlobalData’s analysis, which also evaluates the potential effect and reach of their patenting activity across various applications and regions.
GlobalData estimates that more than 70 businesses are involved in the creation and use of microfluidic lab-on-a-chip, including technology suppliers, well-known manufacturers of medical devices, and burgeoning start-ups.
